Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 3, 2024
FRANKLIN LAKES, N.J. (October 3, 2024) – BD (Becton, Dickinson and Company), a global leader in medical technology, will highlight its newest innovations in drug delivery systems at CPhI Milan 2024
-
Oct 2, 2024
No admission of liability or wrongdoing; settlement structured to eliminate uncertainty for all stakeholders related to settled cases. Settlement amount within current product litigation reserve...
-
Oct 1, 2024
FRANKLIN LAKES, N.J. (Oct. 1, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Connor Bates has been named worldwide...
-
Sep 26, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data that highlights how its advanced artificial intelligence technology can help...
-
Sep 18, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe and the...
-
Sep 12, 2024
FRANKLIN LAKES, N.J. (September 12, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named to TIME’s 2024...
-
Sep 6, 2024
Study Reports Lower Rate of Central Line Bloodstream Infections, Fewer Occlusions and Cost Savings FRANKLIN LAKES, N.J. (Sept. 6, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a...
-
Sep 3, 2024
Expands BD's portfolio of smart connected care solutions with leading monitoring technologies, including advanced AI-enabled clinical decision tools Combination of leading monitoring and infusion...
-
Aug 28, 2024
Columbus, NE – The Columbus Area Chamber of Commerce is excited to announce it has received an additional Rural Workforce Housing Fund award. The award will add $755,000 to the $400,000...
-
Aug 22, 2024
Emphasizes Value of Domestic Production of Critical Medical Devices FRANKLIN LAKES, N.J., Aug. 22, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...
-
Aug 20, 2024BD Earns Top Score on Disability Equality Index, Named a Best Place to Work for Disability Inclusion
FRANKLIN LAKES, N.J. (August 20, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named a Best Place to Work...
-
Aug 12, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michael Feld has been named executive vice president and president of the Life...
-
Aug 8, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 2024 Healthcare Conference on Wednesday,...
-
Aug 1, 2024
FRANKLIN LAKES, N.J. (Aug. 1, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Patrick Jeukenne has been named worldwide...
-
Aug 1, 2024
Strong Margin Execution Drives Performance in Quarter Revenue of $5.0 billion as reported, adjusted revenue of $5.1 billion, driven by strong organic revenue growth GAAP and adjusted diluted EPS...
-
Jul 25, 2024
Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J., July 25, 2024 /PRNewswire/ -- BD (Becton, Dickinson and...
-
Jul 23, 2024
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common...
-
Jul 10, 2024
Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J., July 10, 2024 /PRNewswire/ -- BD (Becton, Dickinson and...
-
Jul 10, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has surpassed its Scope 1 and 2 science-based greenhouse gas (GHG) emissions...
-
Jul 3, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its third quarter of fiscal year 2024 on...
-
Jun 26, 2024
BD Rhapsody™ ATAC-Seq Assay Helps Researchers Understand DNA Regulation and Enable Advancements in Precision Medicine FRANKLIN LAKES, N.J., June 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson...
-
Jun 20, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it plans to host webcasts to discuss quarterly financial results on the following...
-
Jun 13, 2024
FRANKLIN LAKES, N.J. (June 13, 2024) – BD (Becton, Dickinson and Company), a leading global medical technology company, today released its 2023 Product Security Annual Report to update customers...
-
Jun 6, 2024
FRANKLIN LAKES, N.J. (June 6, 2024) – BD (Becton, Dickinson and Company), a leading global medical technology company, was named to USA TODAY’s 2024 list of America’s Climate Leaders,...
-
Jun 3, 2024
Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to BD revenue growth, adjusted gross margin, adjusted operating margin and adjusted EPS...
-
May 15, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) approval for the use of self-collected vaginal...
-
May 13, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Rima Alameddine has been named worldwide president of the BD Peripheral Intervention business unit, effective today.
-
May 6, 2024
New program to equip future pharmacists with industry exposure and hands-on experience with medication dispensing technology FRANKLIN LAKES, N.J. (May 6, 2024) – BD (Becton, Dickinson and...
-
May 2, 2024
Margin Execution Drives Better Performance in Quarter and Higher Guidance for Fiscal 2024 Q2 revenue of $5.0 billion increased 4.6% as reported, 4.7% currency-neutral and 5.7% organic Q2 GAAP and...
-
Apr 30, 2024
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common...
-
Apr 29, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference 2024 on...
-
Apr 9, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health "Best Employers: Excellence in Health...
-
Apr 5, 2024
New BD FACSDiscover™ S8 Cell Sorters to Enable More Researchers to Push the Boundaries of Discovery FRANKLIN LAKES, N.J., April 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:...
-
Apr 4, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its second quarter of fiscal year 2024 on...
-
Mar 27, 2024
Most Americans Unaware of Challenges from Common Hospital Procedures FRANKLIN LAKES, N.J., March 27, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...
-
Mar 26, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2024 list of America's Most Innovative Companies. "At BD, innovation is...
-
Mar 21, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the March 19, 2024 U.S. Food and Drug Administration...
-
Mar 18, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and a consortium of health care institutions in Denmark have innovated a method to recycle used blood...
-
Mar 14, 2024
Program Expands Access to Advanced Testing for Bloodstream Infections and Sepsis Management at More Than 150 Hospitals and Clinics WARSAW (March 14, 2024) – BD (Becton, Dickinson and Company)...
-
Mar 13, 2024
Results Show Clinical Workflow, Operational Efficiency and Financial Improvements When Using Automated Dispensing Cabinets FRANKLIN LAKES, N.J., March 13, 2024 /PRNewswire/ -- BD (Becton,...
-
Mar 11, 2024
FRANKLIN LAKES, N.J. (Mar 11, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Rian Seger has been named president of the...
-
Mar 4, 2024
First Patient Enrollment in AGILITY Study Begins Investigations of Safety and Effectiveness of BD Vascular Covered Stent for Treatment of PAD FRANKLIN LAKES, N.J., March 4, 2024 /PRNewswire/ -- BD...
-
Feb 28, 2024
FRANKLIN LAKES, N.J. (Feb. 28, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Nikos Pavlidis has been named president...
-
Feb 27, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Dave Hickey has informed the company of his intent to retire from BD, effective...
-
Feb 21, 2024
First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV Testing SINGAPORE, Feb. 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading...
-
Feb 15, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: Citi's 2024 Unplugged...
-
Feb 12, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series — which will...
-
Feb 1, 2024
Margin Execution Drives Better Performance in Quarter and Higher Guidance for Fiscal 2024 Q1 revenue of $4.7 billion increased 2.6% as reported, 1.6% currency-neutral and 2.4% organic Q1 GAAP and...
-
Jan 30, 2024
AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous Lesions FRANKLIN LAKES, N.J. and OREM, Utah, Jan. 30, 2024...
-
Jan 25, 2024
Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates NAIROBI, Kenya, Jan. 25, 2024 /PRNewswire/ -- BD (Becton,...